Simplex Trading’s Immune Design Corp. IMDZ Stock Holding History

Simplex Trading’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-273	Closed	-$94K	–	8550
2018 Q3	$94K	Sell	273 -120	-31%	-$451	﹤0.01%	4502
2018 Q2	$178K	Buy	+393	New	+$1.57K	﹤0.01%	3634
2017 Q4	–	Sell	-70	Closed	-$11K	–	7358
2017 Q3	$11K	Buy	+70	New	+$689	﹤0.01%	3746
2017 Q2	–	Sell	-20	Closed	-$5K	–	7462
2017 Q1	$5K	Buy	+20	New	+$116	﹤0.01%	4708

Simplex Trading's IMDZ Position: Q2 2019 in Review

Simplex Trading sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 2,400 shares — an estimated $14K sold.

Simplex Trading first reported a position in IMDZ in Q4 2017 and held it in 3 quarters. The position peaked at $38K in Q4 2017. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

Simplex Trading reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
Simplex Trading sold 2,400 Immune Design Corp. shares in Q2 2019, an estimated $14K.
Simplex Trading first reported a position in Immune Design Corp. in Q4 2017 and held it in 3 quarters.
Simplex Trading's Immune Design Corp. position peaked at $38K in Q4 2017.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Simplex Trading's 13F filing for Q2 2019, filed 26 Jul 2019.